BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 81 filers reported holding BELLICUM PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.15 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $298,000 | -52.0% | 175,003 | -5.0% | 0.00% | – |
| Q1 2019 | $621,000 | +108.4% | 184,310 | +80.8% | 0.00% | – |
| Q4 2018 | $298,000 | +272.5% | 101,928 | +676.3% | 0.00% | – |
| Q3 2018 | $80,000 | -16.7% | 13,130 | +0.5% | 0.00% | – |
| Q2 2018 | $96,000 | -18.6% | 13,060 | -6.5% | 0.00% | – |
| Q4 2017 | $118,000 | -95.0% | 13,970 | -92.7% | 0.00% | -100.0% |
| Q1 2017 | $2,375,000 | +17.4% | 192,501 | +29.6% | 0.00% | 0.0% |
| Q4 2016 | $2,023,000 | – | 148,546 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EMORY UNIVERSITY | 95,215 | $1,297,000 | 1.28% |
| Baker Brothers Advisors | 4,865,647 | $66,270,000 | 0.65% |
| Eventide Asset Management | 250,000 | $3,405,000 | 0.22% |
| MCDANIEL TERRY & CO | 76,112 | $1,037,000 | 0.22% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 82,538 | $1,124,000 | 0.15% |
| QVT Financial LP | 337,923 | $4,603,000 | 0.14% |
| KENNEDY CAPITAL MANAGEMENT LLC | 478,465 | $6,517,000 | 0.11% |
| Vident Investment Advisory, LLC | 47,157 | $642,000 | 0.08% |
| Tekla Capital Management LLC | 60,000 | $817,000 | 0.04% |
| First Eagle Investment Management, LLC | 775,254 | $10,559,000 | 0.03% |